AKIMA FACILITIES OPERATIONS LLC - THE REASON FOR THIS TASK ORDER IS TO: 1. EXTEND SERVICES FOR NINE (9) MONTHS CHANGING THE PERIOD OF PERFORMANCE TO OCTOBER 1, 2025 - JUNE 30, 2026. 2. PROVIDE ONE MONTH OF FUNDING OCTOBER 2025 - OCTOBER 31 2025, INCREASING THE CONTRACT BY $1,235,04
Key Details
Description
THE REASON FOR THIS TASK ORDER IS TO: 1. EXTEND SERVICES FOR NINE (9) MONTHS CHANGING THE PERIOD OF PERFORMANCE TO OCTOBER 1, 2025 - JUNE 30, 2026. 2. PROVIDE ONE MONTH OF FUNDING OCTOBER 2025 - OCTOBER 31 2025, INCREASING THE CONTRACT BY $1,235,04
Context & Analysis
On Jan 27, 2026, Department of Health and Human Services obligated $6,190,137.06 to AKIMA FACILITIES OPERATIONS LLC for the reason for this task order is to: 1. extend services for nine (9) months changing the period of performance to october 1, 2025 - june 30, 2026. 2. provide one month of funding october 2025 - octob…. The award is classified under NAICS 561210 — FACILITIES SUPPORT SERVICES and issued as a firm fixed price contract. Competition extent: not competed. Performance is located in BETHESDA, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 561210 — related awards are listed below.
Contractor Information
Similar Awards
IGF::OT::IGF MANAGEMENT, OPERATION, PROFESSIONAL, AND TECHNICAL SUPPORT SERVICES FOR NIAID ANIMAL CARE FACILITIES
CHARLES RIVER LABORATORIES, INC.
$112.0M
HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23
LEIDOS BIOMEDICAL RESEARCH INC
$72.3M
ATLANTA OM
FOUR SEASONS ENVIRONMENTAL INC
$51.0M
ATLANTA OM
FOUR SEASONS ENVIRONMENTAL INC
$46.9M
IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
LEIDOS BIOMEDICAL RESEARCH INC
$27.5M
Stay Updated
Get notified about new opportunities matching your interests.